Cattle and sheep that had received a primary course of vaccination with an inactivated bluetongue virus serotype 8 (BTV-8) vaccine were booster vaccinated 6 or 12 months later with the homologous vaccine or an alternative inactivated BTV-8 vaccine and neutralising antibody responses were determined. Antibody titres to the alternative vaccine were significantly higher than to the homologous vaccine (P=0.013) in cattle. There was no significant difference between the antibody responses to alternative and homologous vaccines in sheep. These data indicate that cattle and sheep primed with one inactivated BTV-8 vaccine may be effectively boosted with an alternative commercial inactivated BTV-8 vaccine.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tvjl.2010.04.001DOI Listing

Publication Analysis

Top Keywords

btv-8 vaccine
16
antibody responses
12
cattle sheep
12
inactivated btv-8
12
neutralising antibody
8
commercial inactivated
8
inactivated bluetongue
8
bluetongue virus
8
virus serotype
8
homologous vaccine
8

Similar Publications

Parameterisation of a bluetongue virus mathematical model using a systematic literature review.

Prev Vet Med

November 2024

The Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, School of Life Sciences and Mathematics Institute, University of Warwick, Coventry CV4 7AL, UK.

Article Synopsis
  • Bluetongue virus (BT) affects various livestock species worldwide, causing economic losses and health issues, with most existing epidemiological models based on the BTV-8 outbreak from 2006-2009.
  • The study aims to create a flexible model for predicting BT outbreaks globally and to identify key factors influencing outbreak dynamics for better policy planning.
  • A two-host, two-vector model was developed and analyzed using updated parameters from literature, showing that factors like the infectious period of sheep and cows most significantly affect outbreak length and peak infection levels.
View Article and Find Full Text PDF
Article Synopsis
  • In 2023, an outbreak of bluetongue virus serotype 3 (BTV-3) in the Netherlands severely affected ruminants, particularly causing clinical signs and mortality in sheep.
  • Data from monitoring systems showed BTV-3 infections confirmed in multiple animal species, with sheep experiencing the most severe effects.
  • The study suggests that BTV-3 might persist through winter, emphasizing the need for effective vaccines to mitigate future outbreaks.
View Article and Find Full Text PDF

Spatial Transmission Characteristics of the Bluetongue Virus Serotype 3 Epidemic in The Netherlands, 2023.

Viruses

April 2024

Department of Epidemiology, Bioinformatics, Animal Studies and Vaccine Development, Wageningen Bioveterinary Research, P.O. Box 65, 8200 AB Lelystad, The Netherlands.

A devastating bluetongue (BT) epidemic caused by bluetongue virus serotype 3 (BTV-3) has spread throughout most of the Netherlands within two months since the first infection was officially confirmed in the beginning of September 2023. The epidemic comes with unusually strong suffering of infected cattle through severe lameness, often resulting in mortality or euthanisation for welfare reasons. In total, tens of thousands of sheep have died or had to be euthanised.

View Article and Find Full Text PDF

Bluetongue is an economically important disease of domesticated and wild ruminants caused by bluetongue virus (BTV). There are at least 36 different serotypes of BTV (the identity of which is determined by its outer-capsid protein VP2), most of which are transmitted by biting midges. IFNAR mice immunised with plant-expressed outer-capsid protein VP2 (rVP2) of BTV serotypes -1, -4 or -8, or the smaller outer-capsid protein rVP5 of BTV-10, or mock-immunised with PBS, were subsequently challenged with virulent strains of BTV-4 or BTV-8, or with an attenuated clone of BTV-1 (BTV-1RG).

View Article and Find Full Text PDF

Since the outbreak of bluetongue in Northern Europe in 2006, numerous outbreaks involving several serotypes have been observed. Since 2008, compulsory or voluntary vaccination campaigns with inactivated vaccines have been carried out to eradicate these serotypes. In France, serotypes 8 and 4 have been enzootic since 2017, and currently, the majority of vaccinations take place in the context of animal movements, to comply with the regulations of the importing countries.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!